5

PRIMARY DOCUMENT

Company: AXIM BIOTECHNOLOGIES, INC.
Filed: January 5, 2012
Period of Report: December 31, 2011
Accession Number: 0001514946-12-000001

View Document ↗ View on SEC.gov ↗